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Summary
Background: In nematodes, plants, and fungi, RNAi is remark-
ably potent and persistent due to the amplification of initial
silencing signals by RNA-dependent RNA polymerases
(RdRPs). In Caenorhabditis elegans (C. elegans), the interac-
tion between the RNA-induced silencing complex (RISC)
loaded with primary small interfering RNAs (siRNAs) and the
target messenger RNA (mRNA) leads to the recruitment of
RdRPs and synthesis of secondary siRNAs using the target
mRNA as the template. The mechanism and genetic require-
ments for secondary siRNA accumulation are not well
understood.
Results: From a forward genetic screen for C. elegans genes
required for RNAi, we identified rde-10, and through proteomic
analysis of RDE-10-interacting proteins, we identified a protein
complex containing the new RNAi factor RDE-11, the known
RNAi factors RSD-2 and ERGO-1, and other candidate RNAi
factors. The RNAi defective genes rde-10 and rde-11 encode
a novel protein and a RING-type zinc finger domain protein,
respectively. Mutations in rde-10 and rde-11 genes cause
dosage-sensitive RNAi deficiencies: these mutants are resis-
tant to low dosage but sensitive to high dosage of double-
stranded RNAs. We assessed the roles of rde-10, rde-11, and
other dosage-sensitive RNAi-defective genes rsd-2, rsd-6,
and haf-6 in both exogenous and endogenous small RNA
pathways using high-throughput sequencing and qRT-PCR.
These genes are required for the accumulation of secondary
siRNAs in both exogenous and endogenous RNAi pathways.
Conclusions: The RDE-10/RDE-11 complex is essential for
the amplification of RNAi in C. elegans by promoting
secondary siRNA accumulation.
Introduction
RNAi and related small RNA pathways regulate a broad range
of processes including antiviral defense, heterochromatin
formation, genome surveillance, and gene expression in
animals, plants, and fungi [1]. In C. elegans, RNAi is initiated
by the introduction of long double-stranded RNAs (dsRNAs)*Correspondence: ruvkun@molbio.mgh.harvard.eduthat associate with the dsRNA-binding protein RDE-4 and
are processed intow21–24 nt primary small interfering RNAs
(siRNAs) by the RNase III-related enzyme Dicer (DCR-1) [2–4].
Primary siRNAs are loaded onto the RNA-induced silencing
complex (RISC) containing the Argonaute protein RDE-1 and
trigger sequence-specific degradation of messenger RNAs
(mRNAs) complementary to the loaded siRNAs [5, 6]. The initial
RNAi response is amplified by the recruitment of RNA-depen-
dent RNA polymerases (RdRPs) (e.g., RRF-1 and EGO-1) onto
target mRNAs [6–11]. RdRPs dramatically increase the effec-
tiveness of RNAi by catalyzing unprimed synthesis of secon-
dary siRNAs using target mRNAs as templates [8–11]. Secon-
dary siRNAs are far more abundant than primary siRNAs
and correspond to target mRNA sequences both upstream
and downstream of the initial dsRNA trigger [8–11]. Secondary
siRNAs associate with a family of worm-specific Argonautes
(WAGOs) and potentiate the RNAi response by promoting
target mRNA decay and cotranscriptional silencing [6, 12, 13].
Deep sequencing of small RNAs has revealed an extensive
repertoire of endogenous siRNAs in many organisms. These
endogenous siRNAs play essential roles in maintaining
genome integrity at both transcriptional and posttranscrip-
tional levels. In C. elegans, the endogenous siRNAs can be
classified into ERGO-1 class 26G, ALG-3/4 class 26G, CSR-1
class 22G, and WAGO class 22G siRNAs, based on their
length, 50 nucleotide composition, and Argonaute binding
partners. 26G siRNAs are primary siRNAs, and their biogen-
esis requires DCR-1, the 30–50 exonuclease ERI-1, and the
RdRP RRF-3 [14–17]. ERGO-1 class 26G siRNAs function in
oocytes and embryos [14, 16], whereas ALG-3/4 class 26G
siRNAs are required for normal sperm development [14, 17].
ERGO-1 class 26G siRNAs silence recently acquired dupli-
cated genes, and their accumulation requires the helicase
ERI-6/7 and several mutator proteins (proteins first identified
as being required for the silencing of transposons) [18, 19].
Biogenesis of 22G siRNAs requires the DCR-related helicase
DRH-3, as well as the RdRPs EGO-1 and RRF-1 [12]. CSR-1
class 22G siRNAs are derived from germline-expressed genes
and promote chromosome segregation [20]. WAGO class 22G
siRNAs silence transposons, pseudogenes, cryptic loci, and
coding genes in germline and soma [6, 12]. A subset of
WAGO class 22G siRNAs are derived from 26G siRNA targets
and are dependent on 26G siRNA pathway components for
their formation [14–18]. In addition to posttranscriptional
downregulation of target mRNAs in the cytoplasm, certain
WAGO class 22G siRNAs that function downstream of
ERGO-1 class 26G siRNA pathway also direct cotranscrip-
tional silencing of target genes through association with the
Argonaute NRDE-3 in the nuclei of somatic cells [13].
We identified components of a novel protein complex from
a forward genetic screen and by mass spectrometry analysis.
The key components of this complex are encoded by two new
RNAi defective (rde) genes, rde-10 and rde-11. rde-10
encodes a protein only conserved within the nematodes that
lacks known functional domains, and rde-11 encodes
a RING-type zinc finger domain protein. The RDE-10/RDE-11
complex also contains known RNAi pathway components
RSD-2 and ERGO-1. Mutations in rde-10 and rde-11 genes
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Figure 1. Identification of rde-10 and rde-11
(A) A schematic diagram of the EMS mutagenesis screen.
(B and C) Schematic diagrams of the rde-10 and rde-11 genes and identified alleles. Gray boxes, exons; white boxes, 50 and 30 UTRs. See also Figure S1.
Current Biology Vol 22 No 10
882cause a dosage-sensitive RNAi-defective phenotype in that
they fail to respond to dsRNAs at relatively low concentrations
but are sensitive to dsRNAs at relatively high concentra-
tions. High-throughput sequencing data indicates that the
RDE-10/RDE-11 complex is essential for the accumulation of
secondary siRNAs that potentiate the silencing effect of
primary siRNAs. In addition, by high-throughput sequencing
and qRT-PCR, we show that rde-10 and rde-11, as well as
several other dosage-sensitive rde genes (e.g., rsd-2, rsd-6,
and haf-6), regulate the biogenesis and/or stability of an over-
lapping subset of endogenous WAGO class 22G siRNAs. A
substantial fraction of these 22G siRNAs are secondary to
ERGO-1 class 26G siRNAs and target recently acquired dupli-
cated genes. Taken together, our results demonstrate that the
dosage-sensitive rde genes are essential for secondary siRNA
accumulation to promote efficient exogenous and endoge-
nous RNAi in C. elegans.
Results
Identification of the rde-10 Gene from a Forward Genetic
Screen
To identify factors required for RNAi or the spreading of
silencing signals between tissues, we designed a transgene
that initiates RNAi in the nervous system targeting a gfp fusion
gene that is more broadly expressed. The RNAi-inducing
transgene expresses a gfp hairpin dsRNA under the control
of the panneuronal snb-1 promoter (Figure 1A). We introduced
the neuronal RNAi-inducing transgene into sur-5::gfp trans-
genic C. elegans, which express nuclear-localized GFP in
most somatic cells and most prominently in intestinal cells.
Although the in vivo expressed gfp dsRNA does not affect
GFP expression in the neurons, consistent with previous
observations showing that neurons are refractory to RNAi,
gfp dsRNA spreads to other tissues and potently silences
GFP signal in the intestine, muscle, and hypodermis. Next
we mutagenized the strain using ethyl methanesulfonate
(EMS) and screened for mutations that reanimated GFP
expression in somatic tissues.
Sixty-three mutants with a heritable GFP desilencing
phenotype were isolated. The first gene identified wasrde-10 encoded by Y47G6A.4 (Figure 1B). Three presump-
tive null alleles, mg458(Arg96Stop), hj19(Gln12Stop), and
hj20(Gln73Stop), were identified from this screen and from
an independent genetic screen for suppressors of transgene
silencing (H. Yang and H.Y. Mak, personal communication).
The RDE-10 protein contains 627 amino acids (aa) and lacks
obvious conservation outside of Caenorhabditis species but
is highly conserved within this clade. rde-10 mutants were
resistant to many different ingested dsRNAs that target germ-
line-expressed or somatically-expressed genes, including
pos-1, elt-2, lin-29, nhr-23, unc-15, and unc-54 dsRNAs
(see Figure S1A available online). A transgene composed of
a genomic DNA fragment containing the rde-10 coding
sequence plus 770 bp upstream and 200 bp downstream
including the probable 30 UTR rescues an rde-10 null mutant
to normal RNAi response to ingested lin-29 dsRNA, confirming
that defects in the rde-10mutants were directly caused by loss
of rde-10 activity (Figures S1B–S1E).
Unlike certain RNAi pathway mutants that are sterile at
elevated temperatures, rde-10 mutants produce a normal
brood size compared to wild-type (WT) at either 20C or
25C, indicating that rde-10 is not essential for germline devel-
opment (Figure S1F) [21, 22].
RDE-10 and RDE-11 Form a Complex that Mediates
Exogenous RNAi
To identify other RNAi pathway components that function
together with RDE-10, we performed immunoprecipitation of
epitope-tagged RDE-10 followed by tandem mass spectrom-
etry analysis. Transgenic strains were generated expressing
a 33FLAG::GFP::rde-10 fusion construct under the control of
rde-10 50 and 30 regulatory sequences. The epitope-tagged
rde-10 transgene can rescue the RNAi defective phenotype
of rde-10 mutants. A control strain was generated expressing
a 33FLAG::GFP fusion construct under the control of the same
regulatory sequences. The RDE-10 protein complex was puri-
fied using the anti-GFPmonoclonal antibody 3E6 or anti-FLAG
monoclonal antibody M2, and components of the isolated
protein complex were identified by tandem mass spectrom-
etry analysis. Besides the RDE-10 protein, we identified w84
proteins that coimmunoprecipitated with GFP and/or FLAG
Table 1. A Major RDE-10 Protein Interactor Is Encoded by rde-11
(B0564.11), see also Table S1
Gene Sample % Coverage
Number
of unique
peptides
Number
of total
peptides
Total %
coverage
rde-10 rde-10 OE*,
GFP IP
56.1 35 53 72.2
rde-10 SCI+,
GFP IP
26.6 14 21
rde-10 OE,
FLAG IP
38.9 20 20
rde-11 rde-10 OE,
GFP IP
33.2 12 17 58.5
rde-10 SCI,
GFP IP
21.2 6 6
rde-10 OE,
FLAG IP
25.9 7 7
*, overexpression; +, single-copy insertion.
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Figure 2. rde-10 and rde-11 are Dosage-Sensitive RNAi-Defective Mutants
(A) Synthesized pos-1 dsRNA was injected into both gonads of WT, rde-10,
rde-11, rrf-1, and rde-1 day 1 adult worms, and the total number of viable
progeny was counted. gfp dsRNA was introduced by gonadal injection
and served as controls for brood size. All error bars are SD calculated
from 5–10 biological replicates.
(B) Northern blot assays of pos-1 siRNAs (as indicated by the arrow).
V and P, total RNAs extracted from worms fed with vector control and
pos-1 dsRNA, respectively. rde-4 mutant was used as a control for lack of
siRNA accumulation. 5S ribosomal RNAs (rRNAs) stained with ethidium
bromide are shown as a loading control.
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883antibodies from 33FLAG::GFP::rde-10-transgenic C. elegans
but were absent in control coimmunoprecipitations from
33FLAG::GFP-transgenic and WT C. elegans (Table S1). The
most significant interactor of RDE-10, RDE-11, is encoded by
B0564.11 (Table 1; Figure 1C). The RDE-11 proteinwas present
in all RDE-10 coimmunoprecipitation experiments and showed
an abundance close to RDE-10 itself, implying that RDE-10
and RDE-11 form a tight complex (Table S1). The RING-type
zinc-finger domain containing RDE-11 protein is 316 aa long
and conserved in other nematodes at about the same level
of conservation as RDE-10.
A mutant allele of rde-11, hj37(Trp117Stop), was isolated in
the genetic screen for transgene desilencing (Figure 1C).
Similar to rde-10 mutants, the rde-11 mutant is resistant to
feeding RNAi but is not temperature-sensitive sterile (Figures
S1A and S1F). A mutant of a close paralog of rde-11,
Y75B8A.10, does not show defects in RNAi (Figures S1G
and S1H).
Several validated small RNA pathway components were
identified in our proteomic analysis of RDE-10 interacting
proteins (Table S1), including ERGO-1, a primary Argonaute
associated with endogenous 26G siRNAs, RSD-2, and the
RISC component VIG-1 [6, 23, 24].
Mutations in rde-10 and rde-11 Cause Dosage-Sensitive
RNAi-Defective Phenotype
To dissect the roles of rde-10 and rde-11 in exogenous RNAi,
we analyzed the response of rde-10 and rde-11 mutants to
different concentrations of pos-1 dsRNA targeting a germ-
line-essential gene. Feeding the worms with E. coli that
produce dsRNAs delivers very low concentrations of dsRNAs,
whereas injection can introduce dsRNAs at a wide range of
concentrations. WT C. elegans were sensitive to feeding and
injectedpos-1dsRNA and produced dead embryos (Figure 2A;
Figure S1A). rde-10 and rde-11 mutants were resistant to
feeding pos-1 dsRNA and produced a full brood of viable
progeny (Figure S1A). rde-10 and rde-11 mutants were
partially resistant to pos-1 dsRNA injected at low concentra-
tions (e.g., 0.5 ng/ml), producing a brood of w80 to 180
progeny, but were sensitive to pos-1 dsRNA injected at higher
concentrations (e.g., 20 ng/ml and 200 ng/ml), causing embry-
onic lethality, similar to WT (Figure 2A). The rrf-1 mutants
were sensitive to pos-1 dsRNA even at low concentrations
presumably because rrf-1 and ego-1 function redundantly inthe germline for the biogenesis of secondary siRNAs (Fig-
ure 2A) [7, 8]. The rde-1mutants were resistant to high concen-
trations of pos-1 dsRNA because these mutants do not
produce functional primary or secondary siRNAs (Figure 2A).
The dosage-sensitive phenotype of rde-10 and rde-11
mutants suggests that the RDE-10/RDE-11 complex regulates
the efficacy of the exogenous RNAi pathway.
To determine whether rde-10 and rde-11 affect siRNA accu-
mulation in response to exogenous RNAi, we performed
northern blot assays with RNA isolated from WT, rde-10, and
rde-11 mutant animals fed with pos-1 dsRNA. pos-1 siRNAs
at about 21–24 nt were readily detectable in WT (Figure 2B,
lanes 1, 2, 7, and 8) but were absent in rde-10 and rde-11
mutant animals (Figure 2B, lanes 3, 4, and 9–12), as well as in
rde-4 mutants that are defective at an early step in RNAi (Fig-
ure 2B, lanes 5, 6, 13, and 14) [2]. These results indicate that
rde-10 and rde-11 are required for the formation or stability
of siRNAs.
rde-11 Is Required for the Biogenesis of Secondary siRNAs
in Response to Exogenous RNAi
To determine whether rde-10 and rde-11 regulate the biogen-
esis of either primary or secondary siRNAs, we analyzed small
RNAs from WT and rde-11mutant animals exposed to exoge-
nous pos-1 dsRNA by high-throughput sequencing. Primary
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Figure 3. rde-11 Mutants Fail to Accumulate Secondary siRNAs in Response to Exogenous pos-1 RNAi
(A and B) Ratio of pos-1 siRNA reads in rde-11 mutants to WT (WT = 1.0) from total TAP-treated (A) or nontreated (B) RNA.
(C) pos-1 siRNA size and 50 nucleotide distribution in WT and rde-11 mutant worms.
(D) siRNA distribution across the pos-1 genomic region in WT and rde-11mutants. The shaded region indicates the sequence corresponding to the pos-1
dsRNA used for RNAi.
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884siRNAs bear 50 monophosphates and can be captured by 50
ligation using T4 RNA ligase during small RNA library genera-
tion [9, 10]. Secondary siRNAs contain 50 triphosphates, which
are resistant to ligation, and thus require treatment with
tobacco acid pyrophosphatase (TAP) to reduce polyphos-
phates to monophosphates prior to ligation [9, 10]. Because
secondary siRNAs are depleted in libraries in which the small
RNAs are not first subjected to TAP treatment, we developed
small RNA libraries from both nontreated and TAP-treated
RNA to distinguish primary and secondary siRNAs. In TAP-
treated samples, which contain both primary and secondary
siRNAs, pos-1 siRNAs were reduced by w93% in rde-11
mutants compared to WT (Figure 3A). In contrast, in non-
treated samples, which are enriched for primary siRNAs, the
levels of pos-1 siRNAs were similar in WT and rde-11 mutant
animals (Figure 3B).
In WT TAP-treated samples, pos-1 siRNAs were predomi-
nantly 22 nt long and contained 50G, characteristics of
secondary siRNAs (Figure 3C). siRNAs from the nontreated
WT samples were predominantly 23 nt and contained a 50U
or 50A (Figure 3C). This indicates that primary siRNAs are typi-
cally 23 nt, consistent with C. elegans Dicer products [3] and
biased against a 50G. In rde-11 TAP-treated samples, the22 nt 50G-containing siRNAs were depleted and 23 nt 50A-,
50T-, and 50C-containing siRNAs were enriched (Figure 3C).
When plotted along the pos-1 region of genomic DNA
sequence, siRNAs from the TAP-treated samples were pre-
dominantly 22 nt, in the antisense orientation and aligned to
the pos-1 gene sequence (Figure 3D). In nontreated samples,
siRNAswere predominantly 23 nt, of both sense and antisense
orientation, and derived fromboth the pos-1 gene sequence as
well as upstream sequence corresponding to the exogenous
dsRNA used for RNAi treatment (Figure 3D). In rde-11mutants,
siRNAs were uniformly depleted across pos-1 in TAP-treated
samples but were more or less unaffected in nontreated
samples (Figure 3D). Taken together, these data indicate that
rde-11 is essential for the accumulation of secondary siRNAs
but dispensable for the biogenesis of primary siRNAs. Addi-
tionally, the results suggest that primary siRNAs can be distin-
guished from secondary siRNAs by their length and 50 nt.
Mutations in rde-10 and rde-11Affect the Levels of a Subset
of WAGO Class Endogenous 22G siRNAs Downstream
of ERGO-1 Class 26G siRNAs
To determine whether rde-10 and rde-11 act in the pathways
that produce primary or secondary endogenous siRNAs, we
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Figure 4. rde-10 and rde-11 Genes Regulate the Levels of a Subset of WAGO Class 22G siRNAs
(A) Ratio of O1 26G siRNA in rde-10 and rde-11mutant embryos to WT after log2 transformation as determined by Taqman qRT-PCR (WT = 0; i.e., log2 1.0).
Total RNA extracted from mut-16 was used as a negative control. miR-35 was used for normalization.
(B) Ratio of S5 26G siRNA in rde-10 and rde-11 mutant L4 larvae and young adults to WT after log2 transformation as determined by Taqman qRT-PCR
(WT = 0; i.e., log2 1.0). Total RNA extracted from eri-1 was used as a negative control. let-7 was used for normalization.
(C) Ratio of X-cluster siRNA in variousmutant strains at the adult stage toWT after log2 transformation as determined by Taqman qRT-PCR (WT = 0; i.e., log2
1.0). Total RNA extracted from eri-1was used as a negative control. miR-1 was used for normalization. All error bars are SD calculated from three technical
replicates.
(D) Northern blot assays of X-cluster and eri-6 (T01A4.3) siRNAs. 5S rRNAs stained with ethidium bromide are shown as a loading control. Total RNAs were
extracted from day 1 gravid adult worms. eri-1mutant was used as a negative control for X-cluster siRNA expression, whereasmut-7mutant was used as
a negative control for X-cluster and eri-6 (T01A4.3) siRNA expression.
(E) Small RNA size and 50 nucleotide distribution in WT and rde-10mutant day 1 gravid adult worms. Insets show pie charts that display the proportion of
reads corresponding to the indicated features.
(F) Enrichment or depletion of small RNAs in rde-10mutant worms relative to WT worms. Total small RNA reads were calculated for 5 kb bins in 1 kb incre-
ments across each chromosome.
(G) Ratio of 22G siRNA reads derived from ERGO-1 class 26G siRNA target mRNAs in rde-10 and rde-11mutants to WT (WT = 1.0) at embryo and L4 larvae/
young adult stages.
(H) Venn diagrams of rde-10-, rde-11-, and eri-7-dependent siRNAs.
(I) Ratio of NRDE-3 class 22G and upstream ERGO-1 class 26G siRNA reads in rde-10 embryos to WT embryos (WT = 1.0)
(J) Ratio of RRF-3-dependent 22G siRNA reads from somatic target mRNAs in rde-10 and rde-11 mutant embryos to WT embryos (WT = 1.0).
(K) Venn diagrams of rde-10- and rde-11-dependent siRNAs at embryo and L4 larvae/young adult stages.
(L) Ratio of Y47H10A.5 target mRNA levels in rde-10 and rde-11mutants to WT (WT = 1.0) as determined by qRT-PCR. All error bars are SD calculated from
three technical replicates. See also Figure S2 and Tables S2–S7.
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885used Taqman qRT-PCR tomeasure the levels of ERGO-1 class
O1 26G siRNA (C40A11.10), ALG-3/4 class S5 26G siRNA
(ssp-16) and WAGO class X-cluster 22G siRNA [14]. In rde-10
and rde-11 mutants, the levels of O1 26G siRNA were similar
to WT (Figure 4A). In contrast, mut-16 mutants displayed
an w98% reduction in O1 26G siRNA. The levels of S5 26GsiRNA in rde-10 and rde-11 mutants were also indistinguish-
able from WT but greatly reduced in eri-1mutants (Figure 4B).
In contrast to 26G siRNAs, the X-cluster 22G siRNA was
strongly depleted in rde-10 and rde-11 mutants (Figures 4C
and 4D). However, a germline-expressed 22G siRNA, derived
from eri-6 (T01A4.3), was unaffected in rde-10 mutants as
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886determined by northern blot (Figure 4D) [25]. These results
indicate that rde-10 and rde-11 are essential for the formation
or stability of a subset of endogenous siRNAs.
To more broadly assess the roles of rde-10 and rde-11 in
endogenous small RNA pathways, we performed Illumina
deep sequencing of small RNA complementary DNA (cDNA)
libraries derived from WT, rde-10, and rde-11 mutants at
embryo and young adult stages, as well as WT and rde-10
mutants at the day 1 gravid adult stage (Figures S2A–S2C).
Small RNA libraries from adult WT and rde-10 mutant animals
showed similar size and 50 nt distribution, with the most
abundant species being 22 nt long and containing a 50G
(Figure 4E). MicroRNAs (miRNAs) and siRNAs derived from
predicted coding genes were the predominant classes of
small RNAs (Figure 4E, insets). None of the known classes
of small RNAs were broadly depleted in rde-10 mutants,
although several clusters of 22G siRNAs were strongly
reduced (Figure 4F). Similar results were observed in rde-10
and rde-11 embryo and young adult libraries (Figures S2D–
S2G). Consistent with our qRT-PCR results (Figures 4A
and 4B), both the ERGO-1 and ALG-3/4 classes of 26G
siRNAswere unaffected in rde-10 and rde-11mutants (Figures
S2D–S2E, the 26 nt peaks in the bar plots are either ERGO-1
class 26G siRNAs in the embryo libraries [Figure S2D] or
ALG-3/4 class 26G siRNAs in the young adult libraries
[Figure S2E]).
To determine whether rde-10 and rde-11 function in
a specific endogenous RNAi pathway, we assessed the
siRNAs depleted in rde-10 and rde-11mutants for their depen-
dence on other endogenous siRNA factors using small RNA
deep sequencing data sets from mut-16, eri-7, and rrf-3
mutants and NRDE-3 and ERGO-1 coimmunoprecipitation
assays [13, 15, 16, 18, 19].mut-16 is essential for the accumu-
lation of WAGO class but not CSR-1 class 22G siRNAs derived
from thousands of genes [12, 19]. eri-7 and rrf-3 are required
for the accumulation of ERGO-1 class 26G siRNAs and their
downstream WAGO class 22G siRNAs that interact with the
Argonaute NRDE-3 [15, 18]. In rde-10 mutant gravid adults,
37 features, which includes coding genes, pseudogenes, and
transposons, that yielded R10 siRNA reads per million total
small RNA reads (RPM) in at least one of the libraries analyzed,
were depleted of siRNAs by 67%ormore, relative toWT (Table
S2). Of these, 34 were also reduced in mut-16 mutant gravid
adults (Table S2) [19]. Thirty-nine features were depleted of
siRNAs in rde-10 mutant embryos, of which 33 were also
reduced inmut-16mutant embryos (Tables S3 and S4). These
results indicate that rde-10 is required for the accumulation of
a subset of WAGO class 22G siRNAs. The majority of rde-10
target genes have multiple paralogs in the genome, which is
characteristic of target genes regulated by the ERGO-1 class
26G siRNAs and their downstream WAGO class 22G siRNAs
[16, 18]. 22G siRNA reads derived from ERGO-1 targets were
reduced by 60% and 20% in rde-10mutant embryo and young
adult libraries, respectively (Figure 4G; Tables S3 and S5).
There was no reduction in the corresponding upstream 26G
siRNAs from ERGO-1 targets. Of the 39 features depleted
of siRNAs in rde-10 mutant embryos, 26 were also depleted
of siRNAs in eri-7 mutant embryos (Figure 4H) [18]. Of the
116 NRDE-3 targets analyzed [13], 28 yielded R10 RPM in
either rde-10 mutant or WT embryo libraries of which 23
were depleted of 22G siRNAs byR50% in rde-10mutants (Fig-
ure 4I). In contrast, 26G siRNA reads from each of the NRDE-3
targets analyzedwere unchanged or slightly elevated in rde-10
mutants relative to WT (Figure 4I). Of 23 previously identifiedRRF-3 target genes [15], 15 yieldedR10 RPM 22G siRNAs in
the WT embryo library and of these, 12 had R50% or more
decrease in 22G siRNA reads in the rde-10 mutant embryos
relative to WT (Figure 4J).
In rde-11mutants, a subset of WAGO class 22G siRNAs was
also depleted (Figures S2D–S2G). Twenty-one out of 41
features depleted of siRNAs by 67% or more in rde-11mutant
embryos were also depleted of siRNAs in mut-16 embryos
(Tables S4 and S6). 22G siRNA reads derived from ERGO-1
target genes were reduced by 20% in both rde-11 mutant
embryos and young adults relative to WT (Figure 4G). This
modest reduction was likely caused by substantial decreases
in 22G siRNA reads derived from a small subset of ERGO-1
target genes (Figure 4H; Tables S6 and S7). There was partial
overlap in the features depleted of siRNAs in rde-10 and
rde-11 mutant embryos and young adults (Figure 4K; Tables
S3 and S5–S7).
WAGO class 22G siRNAs downregulate their targets by trig-
gering both mRNA degradation and cotranscriptional
silencing [12, 13]. The mRNA levels of most of the rde-10 and
rde-11 regulated genes were unchanged in the mutants
compared to WT as measured by qRT-PCR, presumably
because of moderate decrease of siRNA levels. However, the
mRNA levels of Y47H10A.5 gene, which yielded high number
of siRNA reads in the WT and the w80% fewer reads in the
mutants, were upregulated by 4- to 5-fold in rde-10 and
rde-11mutants compared toWT (Figure 4L). The accumulation
of Y47H10A.5 siRNAs requires RDE-1 [26], consistent with
a similar role of the RDE-10/RDE-11 complex downstream of
RDE-1 in endogenous RNAi.
Taken together, these results indicate that rde-10 and
rde-11 are essential for the accumulation of a subset of
WAGO class 22G siRNAs that are primarily derived from
ERGO-1 targets.
rsd-2, rsd-6, and haf-6 Mutants Display siRNA Defects
that Overlap with rde-10 and rde-11 Mutants
RSD-2 interacts with RDE-10 and the TUDOR domain protein
RSD-6 (Table S1) [23]. Given that rsd-2 and rsd-6 mutants
show similar dosage-sensitive RNAi-defective phenotype to
rde-10 and rde-11 mutants, we investigated the specific roles
of these genes in endogenous small RNA pathways. We
measured the levels of ERGO-1 class O1 (C40A11.10) and O2
(E01G4.7) 26G siRNAs, as well as ALG-3/4 class S4 (deps-1)
and S5 (ssp-16) 26G siRNAs by Taqman qRT-PCR assays
(Figures 5A and 5B) [14]. The levels of these 26G siRNAs
were similar to WT in rsd-2 and rsd-6 mutants (Figures 5A
and 5B). However, the levels of the WAGO class X-cluster
22G siRNA were strongly depleted in rsd-2 and rsd-6mutants
relative to WT by both northern blot assay and Taqman qRT-
PCR (Figures 4C and 5C).
To more comprehensively examine the roles of rsd-2 and
rsd-6 in endogenous small RNA pathways, we performed
Illumina deep sequencing of small RNA cDNA libraries derived
from WT, rsd-2, and rsd-6 mutant day one gravid adults
(Figure S2A). The levels of 22G siRNAs derived from several
clusters across the genome were strongly reduced in rsd-2
and rsd-6 mutants relative to WT (Figures S3A and S3B).
Two hundred and sixty features were depleted of siRNAs
by R67% in rsd-2 mutants, of which 223 were also depleted
in mut-16 mutants (Figure S3C; Table S8) [19]. One hundred
and thirteen featureswere depleted of siRNAs in rsd-6mutants
and 106 of these also had reduced siRNA levels in mut-16
mutants (Figure S3D; Table S9) [19]. Of the features depleted
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Figure 5. rsd-2, rsd-6, and haf-6 Are Required for
the Accumulation of a Subset of WAGO Class
22G siRNAs
(A) Ratio of O1 and O2 26G siRNAs in rsd-2 and
rsd-6 mutant embryos to WT embryos after log2
transformation as determined by Taqman qRT-
PCR (WT = 0; i.e., log2 1.0). Total RNA extracted
from eri-1 was used as a negative control.
miR-35 was used for normalization.
(B) Ratio of S4 and S5 26G siRNAs in rsd-2 and
rsd-6 mutant strains to WT at L4 larval/young
adult stage as determined by Taqman qRT-PCR
(WT = 1.0). miR-1 was used for normalization.
(C) Northern blot assays of X-cluster siRNA. 5S
rRNAs stained with ethidium bromide are shown
as a loading control. Total RNA extracted from
WT N2 strain raised at the elevated temperature
25C was used as a negative control of X-cluster
siRNA expression [37].
(D) Venn diagrams of rsd-2-, rsd-6-, and eri-7-
dependent siRNAs.
(E) Venn diagram of rsd-2-, rsd-6-, and rde-10-
dependent siRNAs.
(F) Ratio of Y24F12A.3 and Y47H10A.5 target
mRNA levels in rsd-2 and rsd-6 adults to WT
adults (WT = 1.0) as determined by qRT-PCR.
(G) Ratio of X-cluster and E01G4.5 22G siRNAs in
haf-6 mutant embryos to WT embryos after log2
transformation as determined by Taqman qRT-
PCR (WT = 0; i.e., log2 1.0). miR-35 was used for
normalization.
(H) Ratio of a panel of representative small RNAs
in haf-6 mutant to WT as determined by Taqman
qRT-PCR (WT = 1.0). For O1, O2, B0250.8, and
hcp-1 siRNA assays, total RNAs were extracted
from embryos and miR-35 was used for normali-
zation. For S4 and S5 siRNA assays and the
21UR-1 piRNA assay, total RNAs were extracted
from L4 larvae/young adult worms and miR-1
was used for normalization. All error bars are SD
calculated from three technical replicates. See
also Figure S3 and Tables S8 and S9.
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887of siRNAs in rsd-2 and rsd-6 mutant day 1 gravid adults,
29 and 28 were also depleted of siRNAs in eri-7 mutants,
respectively (Figure 5D) [18]. There was also considerable
overlap between features that were depleted of siRNAs in
rsd-2, rsd-6, and rde-10 mutants (Figure 5E). In addition to
their roles in the accumulation of ERGO-1-dependent 22G
siRNAs, which express in the soma, rsd-2 and rsd-6 also
function in the germline. Ninety-nine and 44 features that
had reduced siRNA levels in rsd-2 and rsd-6mutants, respec-
tively, were derived from genes that are enriched for siRNAs
in the germline (Figures S3E and S3F) [12]. To determine
whether the reductions in siRNA levels observed in rsd-2 and
rsd-6 mutants results in upregulation of the target mRNAs,
we measured the levels of Y24F12A.3 and Y47H10A.5 mRNAsby qRT-PCR (Figure 5F). Y24F12A.3
mRNA levels were increased for more
than 2-fold in rsd-2 and rsd-6 mu-
tants compared to the WT. Y47H10A.5
mRNAs were elevated for 18.2- and
2.2-fold in rsd-2 and rsd-6 mutants,
respectively.
haf-6 mutants also show dosage-
sensitive RNAi-defective phenotype
[27]. haf-6 encodes a half-moleculeATP-binding cassette (ABC) transporter protein. In order to
assess the specific requirements of haf-6 in endogenous small
RNA pathways, we measured the levels of several small RNAs
using Taqman qRT-PCR assays. The levels of ERGO-1-depen-
dent WAGO class X-cluster and E01G4.5-derived 22G siRNAs
were substantially reduced in haf-6 mutants relative to WT
(Figure 5G). In contrast, a germline-enriched WAGO class
22G siRNA derived from B0250.8, whose biogenesis is inde-
pendent of ERGO-1 pathway components, was unaffected
(Figure 5H). In addition, the levels of ERGO-1 class O1 and
O2 26G siRNAs, CSR-1 class hcp-1-derived 22G siRNA, as
well as piRNA 21UR-1, were unchanged in haf-6mutants rela-
tive to WT (Figure 5H) [12, 20, 28]. Interestingly, ALG-3/4 class
26G siRNAs were moderately elevated in haf-6 mutants,
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888indicating that haf-6may negatively regulate the biogenesis of
ALG-3/4 class 26G siRNAs (Figure 5H).
Taken together, our results indicate that rsd-2, rsd-6, and
haf-6 regulate the levels of a subset of WAGO class 22G
siRNAs, many of which are downstream of ERGO-1 class
26G siRNAs and are also dependent on rde-10 and rde-11.
Discussion
In this study, we characterized a new protein complex contain-
ing RDE-10, RDE-11, and RSD-2 that promotes the amplifica-
tion of C. elegans RNAi response. We showed that these
dosage-sensitive RNAi-defective genes affect the biogenesis
and/or stability of secondary siRNAs in both exogenous
and endogenous RNAi pathways (Figure 6). When exogenous
dsRNAs are present at high concentrations, enough primary
siRNAs can be generated by DCR-1 to trigger an RNAi
response, and the function of RDE-10/RDE-11 complex is
dispensable. However, at low dsRNA concentrations, secon-
dary siRNA amplification, which requires the RDE-10/RDE-11
complex, is essential to mediate RNAi. Therefore, these genes
promote the effectiveness of exogenous RNAi.
We showed that rde-10, rde-11, rsd-2, rsd-6, and haf-6
genes are required for the accumulation of a subset of
WAGO class 22G siRNAs (Figure 6). Consistent with the iden-
tification of ERGO-1 in RDE-10 proteomics, our data indicated
that some of these 22G siRNAs act downstream of ERGO-1
class 26G siRNAs and silence target genes expressed in thesoma. In our model (Figure 6), primary 26G siRNA biogenesis
requires DCR-1 and RRF-3, and the target mRNAs are cleaved
by DCR-1 during the biogenesis of primary siRNA duplex [18].
The primary Argonaute ERGO-1 interacts with the primary
siRNA duplex and degrades the passenger strand [18]. The
association between the ERGO-1-bound primary siRNA and
target mRNA leads to recruitment of DRH-3 and RRF-1 for
secondary 22G siRNA biogenesis [12]. DRH-3 and RRF-1 are
not present in the RDE-10 protein complex. However, we iden-
tified ERGO-1 and the RISC component VIG-1 in RDE-10 pro-
teomics. The RDE-10 complex may bridge the step between
primary siRNA target recognition and RDRP recruitment to
facilitate secondary siRNA accumulation. These somatically
expressed secondary siRNAs interact with SAGO-1 and
SAGO-2 in the cytoplasm [6, 12]. These secondary Argonautes
do not have endonuclease activity and may recruit other
cellular mRNA degradation machinery for target mRNA decay.
Secondary siRNAs also interact with NRDE-3 in the nucleus
and silence target gene expression cotranscriptionally [13].
To date, the only published proteomics studies in the
C. elegans RNAi field are the characterization of DCR/ERI
and DRH-3 complexes essential for endogenous 26G and
22G siRNA production, respectively [12, 25]. Our data suggest
that the RDE-10 complex is distinct from and likely functions
subsequent to the DCR/ERI complex and before the DRH-3
complex.
Some of the RDE-10 interacting proteins have been identi-
fied as potential regulators of small RNA pathways in previous
RNAi-based genome-wide screens but have not been further
characterized (e.g., MATH-33 and PAB-1). The MATH-33
protein has ameprin-associated Traf homolog (MATH) domain
and also shares sequence homology with ubiquitin carboxyl-
terminal hydrolases. MATH-33 is required for cosuppression
in the C. elegans germline, an RNAi-related pathway in
which introduction of exogenous repetitive sequences causes
repression of the endogenous homologous genes [29]. PAB-1
is a polyadenylate-binding protein that plays a role in at least
two RNAi-dependent processes, transposon silencing in the
germline as well as transcriptional silencing of a transgene in
the soma [30, 31]. PAB-1 forms a complex with ATX-2, the
C. elegans ataxin-2 ortholog [32]. We also identified ATX-2 in
the RDE-10/RDE-11 protein complex.
We showed that rsd-2, rsd-6, and haf-6 genes regulate the
levels of a subset of WAGO class 22G siRNAs. RSD-2 and
RSD-6 associate with endoplasmic reticulum, whereas
HAF-6 is a plasma membrane protein [23, 27, 33]. It would be
intriguing to identify the physical interactors of these
membrane-associated RNAi factors. A subset of germline-
enriched siRNAs were depleted in rsd-2 and rsd-6 mutants
which may explain the germline-related phenotypes of these
mutants: rsd-2 mutants display elevated levels of germline
transposon mobilization at high temperatures, whereas rsd-6
mutants display high incidence of males, as a result of an
increase in X chromosome nondisjunction, and sterility at
elevated temperatures [33]. Our data suggest that these
dosage-sensitive RNAi-defective genes encode amplification
phase factors that promote and extend the potency of RNAi-
based surveillance.Experimental Procedures
Bristol N2 was used as control WT strain. All strains were incubated at 20C
unless otherwise described. Large-scale immunoprecipitation was per-
formed based on a previously published protocol [34]. dsRNA synthesis
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889and injection were carried out as described [35]. Total RNA isolation, small
RNA northern blot, small RNA deep sequencing, Taqman small RNA qRT-
PCR, and target mRNA qRT-PCR were performed as described [19, 36].
Detailed experimental procedures are in the Supplemental Information.
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